Rxsight Inc reports results for the quarter - Earnings Summary

RxSight

09/11/2024 12:28

* Rxsight Inc  RXST.OQ  reported a quarterly adjusted loss
of 16
cents​​ per share for the quarter , higher than the same quarter
last year, when the company reported EPS of -31 cents.  The mean
expectation of nine analysts for the quarter was for a loss
of 25 cents per share. Wall Street expected results to range
from -34 cents to -18 cents per share.
    * Revenue rose 59.1% to $35.31 million from a year ago;
analysts
expected $35.06 million. 
    * Rxsight Inc's reported EPS for the quarter was a loss
of 16
cents​.
    * The company reported a quarterly loss of $6.34 million.
    * Rxsight Inc shares had risen by 2.9% this quarter and
gained 26.1% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 7.7%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 9 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the medical
equipment,
supplies & distribution peer group is also "strong buy"

Wall Street's median 12-month price target for Rxsight Inc is
65.00 
This summary was machine generated from LSEG data November 9 at
12:28 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      -0.25          -0.16          Beat
 Jun. 30 2024      -0.22          -0.16          Beat
 Mar. 31 2024      -0.27          -0.25          Beat
 Dec. 31 2023      -0.36          -0.26          Beat